597 Preliminary safety, efficacy and pharmacokinetic results of the EP4 antagonist INV-1120 from a first-in-human study in subjects with advanced solid tumors | Zendy

AI Assistant Blog Pricing

597 Preliminary safety, efficacy and pharmacokinetic results of the EP4 antagonist INV-1120 from a first-in-human study in subjects with advanced solid tumors

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.